Company Filing History:
2 out of 15 
2 out of 93 
Years Active: 2024-2025
Title: Yeryoung Yong: Innovator in Bispecific Antibody Development
Introduction
Yeryoung Yong is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of bispecific antibodies. With a total of 2 patents, his work focuses on innovative treatments for cancer.
Latest Patents
Yeryoung Yong's latest patents include the "Anti-HER2/anti-4-1BB bispecific antibody and use thereof." This patent provides an anti-4-1BB/anti-HER2 bispecific antibody, along with a pharmaceutical composition and a method for treating and/or preventing cancer using this innovative approach. Another significant patent is the "Anti-EGFR/anti-4-1BB bispecific antibody," which also offers a method for treating and/or preventing cancer through the use of an anti-4-1BB/anti-EGFR bispecific antibody.
Career Highlights
Throughout his career, Yeryoung Yong has worked with prominent companies in the biopharmaceutical sector, including Abl Bio Inc. and Yuhan Corporation. His experience in these organizations has contributed to his expertise in antibody development and cancer treatment.
Collaborations
Yeryoung has collaborated with talented individuals in his field, including Eun-Jung Lee and Hyejin Chung. These partnerships have likely enhanced his research and development efforts.
Conclusion
Yeryoung Yong is a distinguished inventor whose work in bispecific antibodies is paving the way for innovative cancer treatments. His contributions to the field are noteworthy and reflect his commitment to advancing medical science.